BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38910943)

  • 1. Automated Scoring of Alzheimer's Disease Atrophy Scale with Subtype Classification Using Deep Learning-Based T1-Weighted Magnetic Resonance Image Segmentation.
    Choe YS; Kim REY; Kim HW; Kim J; Lee H; Lee MK; Lee M; Kim KY; Kim SH; Kim JH; Lee JY; Kim E; Kim D; Lim HK
    J Alzheimers Dis Rep; 2024; 8(1):863-876. PubMed ID: 38910943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
    Boutet C; Chupin M; Colliot O; Sarazin M; Mutlu G; Drier A; Pellot A; Dormont D; Lehéricy S;
    Neuroradiology; 2012 Dec; 54(12):1321-30. PubMed ID: 22782577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an automatic classification algorithm for the diagnosis of Alzheimer's disease using a high-performance interpretable deep learning network.
    Park HY; Shim WH; Suh CH; Heo H; Oh HW; Kim J; Sung J; Lim JS; Lee JH; Kim HS; Kim SJ
    Eur Radiol; 2023 Nov; 33(11):7992-8001. PubMed ID: 37170031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry.
    Cheung EYW; Chau ACM; Tang FH; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35455005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability.
    Hurtz S; Chow N; Watson AE; Somme JH; Goukasian N; Hwang KS; Morra J; Elashoff D; Gao S; Petersen RC; Aisen PS; Thompson PM; Apostolova LG
    Neuroimage Clin; 2019; 21():101574. PubMed ID: 30553759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated brain volumetric program measuring regional brain atrophy in diagnosis of mild cognitive impairment and Alzheimer's disease dementia.
    Ryu DW; Hong YJ; Cho JH; Kwak K; Lee JM; Shim YS; Youn YC; Yang DW
    Brain Imaging Behav; 2022 Oct; 16(5):2086-2096. PubMed ID: 35697957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Zhao H; Li X; Wu W; Li Z; Qian L; Li S; Zhang B; Xu Y
    PLoS One; 2015; 10(6):e0130017. PubMed ID: 26066658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.
    Westman E; Cavallin L; Muehlboeck JS; Zhang Y; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Simmons A; Wahlund LO;
    PLoS One; 2011; 6(7):e22506. PubMed ID: 21811624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
    Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
    Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
    Qu H; Ge H; Wang L; Wang W; Hu C
    Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods.
    Zhang B; Xu M; Wu Q; Ye S; Zhang Y; Li Z;
    Front Aging Neurosci; 2024; 16():1328301. PubMed ID: 38894849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer's disease.
    Vuoksimaa E; McEvoy LK; Holland D; Franz CE; Kremen WS;
    Brain Imaging Behav; 2020 Jun; 14(3):787-796. PubMed ID: 30511118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cortical and subcortical structural segmentation methods in Alzheimer's disease: A statistical approach.
    Zamani J; Sadr A; Javadi AH
    J Clin Neurosci; 2022 May; 99():99-108. PubMed ID: 35278936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural correlates of mild cognitive impairment: A clinicovolumetric study.
    Sheelakumari R; Kesavadas C; Lekha VS; Justus S; Sarma PS; Menon R
    Neurol India; 2018; 66(2):370-376. PubMed ID: 29547157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Alzheimer's Disease and Mild Cognitive Impairment Based on Cortical and Subcortical Features from MRI T1 Brain Images Utilizing Four Different Types of Datasets.
    Toshkhujaev S; Lee KH; Choi KY; Lee JJ; Kwon GR; Gupta Y; Lama RK
    J Healthc Eng; 2020; 2020():3743171. PubMed ID: 32952988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.